In a phase 2 trial, firsekibart — an IL-1 beta antibody — outperforms colchicine in preventing acute gout flares over 12 ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Colcrys, a new colchicine formulation, has received marketing clearance for the prevention of gout flares. The FDA first approved the oral medication in July for the treatment of acute gout flares ...
DUBLIN, Nov. 2, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping colchicine 0.6 mg capsules, a ...
A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...
Historical use of colchicine, or its precursors, dates back several thousand years, with reports appearing in records from ancient Egyptians, Greeks and Arabic physicians. Although colchicine has been ...
EKSTROM trial results demonstrate low-dose colchicine, 0.5 mg significantly reduced total plaque volume in stable coronary artery disease compared to placebo at one year PARSIPPANY, N.J., March 31, ...
LONDON (Reuters) - U.S. regulator the Food and Drug Administration (FDA) intends to ban unapproved oral colchicine products to treat gout, according to a document posted online by the U.S. Office of ...
A single dose of the anti-inflammatory drug colchicine before percutaneous artery intervention (PCI) failed to significantly reduce PCI-related myocardial injury or 30-day major adverse cardiovascular ...
Dear Dr. Roach: I’m a 78-year-old man with a stent and a blockage in one of the arteries to my heart. I am on a low-fat diet and take ramipril for cholesterol. My levels are very good (total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback